DEF 14A

Company

GRI Bio, Inc.

Filed

June 6, 2022

Period of Report

July 13, 2022

Accession Number

0001824293-22-000046

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →